Tanshinone iia c6 9
1 / 2

Tanshinone IIA 抑制 C6 神經膠瘤細胞基質 ? 屬蛋白 ?-9 的表現 - PowerPoint PPT Presentation

  • Uploaded on

Tanshinone IIA 抑制 C6 神經膠瘤細胞基質 ? 屬蛋白 ?-9 的表現.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about ' Tanshinone IIA 抑制 C6 神經膠瘤細胞基質 ? 屬蛋白 ?-9 的表現' - wanda-pearson

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Tanshinone iia c6 9
Tanshinone IIA抑制C6神經膠瘤細胞基質?屬蛋白?-9的表現

  • 基質金屬蛋白?(matrix metalloproteinases,MMPs)是調控神經膠瘤細胞(glioma cells)入侵能力的重要因子之ㄧ。Tanshinone IIA是從一種中藥草-丹蔘(Danshen,Radix Salvia miltiorhiza Bunge)中所純化出來的一種活性成分,對抑制腫瘤的生長和入侵有相當好的效果。本論文利用C6 glioma cells探討tanshinone IIA是否會抑制酯多醣(lipopolysaccharide;LPS)和 PMA (phorbol myristate acetate)誘導MMP-9的表現。實驗結果發現,LPS和PMA處理C6 glioma cells會增加MMP-9的蛋白量和活性,而先以tanshinone IIA處理細胞,則會抑制MMP-9的蛋白量和活性。我們也發現tanshinone IIA會增加細胞中血基質氧化酵素-1(heme oxygenase-1;HO-1)的表現,但是預先以活性氧自由基(reactive oxygen species;ROS)的抑制劑l-NAC (l-N-acetylcysteine) 和PI 3-K抑制劑(LY294002)處理細胞,則皆會抑制tanshinone IIA所誘導的HO-1表現。Tanshinone IIA也會增加Akt/PKB的磷酸化,而且tanshinone IIA所增加的Akt/PKB磷酸化會被l-NAC所減少。接下來以SnPP (tin protoporphyrin)去抑制HO-1表現,發現可以減輕tanshinone IIA抑制MMP-9的蛋白量和活性,顯示HO-1在此抑制效應中扮演關鍵的角色。因為HO-1可催化一氧化碳(CO)的產生,而以CO donor (tricarbonyl dichlororuthenium (Ⅱ) dimer)處理細胞,則可以抑制誘導型一氧化碳合成?(iNOS)和MMP-9的表現,反之,以CO清除劑血紅素(hemoglobin)處理細胞,則會減輕tanshinone IIA對MMP-9的抑制作用。由於NOS的抑制劑l-NAME會抑制LPS和PMA誘導MMP-9的蛋白量和活性,很可能tanshinone IIA是透過誘導HO-1表現而達到抑制MMP-9的效果,使HO-1催化CO產生,導致iNOS被抑制,進而減少MMP-9的蛋白量和活性。

Tanshinone iia inhibits matrix metalloproteinase 9 expression in c6 glioma cells
Tanshinone IIA inhibits matrix metalloproteinase-9 expression in C6 glioma cells.

  • Matrix metalloproteinases (MMPs) have been implicated as important factors in the control of the invasive capability of glioma cells. Tanshinone IIA, an active ingredient purified from the Chinese herb Danshen (Radix Salvia miltiorhiza Bunge), is known to exhibit potent effects on tumor progression and invasion. In the present study, we investigated whether tanshinone IIA inhibits LPS (lipopolysaccharide) and PMA (phorbol 12-myristate 13-acetate)-induced MMP-9 gene expression in C6 glioma cells. Treatment of C6 glioma cells with LPS and PMA increased the MMP-9 expression and the expression was inhibited by pretreatment of cells with tanshinone IIA at a concentration that is not toxic to C6 glioma cells. Incubation of C6 glioma cells with tanshinone IIA increased heme oxygenase-1 (HO-1) expression, which was inhibited by pretreatment of cells with l-N-acetylcysteine (l-NAC) prior to addition of tanshinone IIA, suggesting reactive oxygen species (ROS) are involved. Inhibition of PI 3-K/Akt pathway by LY294002 or wortmannin reduced the HO-1 protein expression by tanshinone IIA. In agreement, treatment of cells with tanshinone IIA increased phosphorylation of Akt/PKB, which was attenuated by l-Nac suggesting activation of PI3-kinase–Akt is secondary to ROS production. The inhibition of MMP-9 expression by tanshinone IIA was reversed by tin protoporphyrin (SnPP) suggesting tanshinone IIA may exert this inhibitory effect through HO-1. Increase of HO-1 expression catalyzes carbon monoxide (CO) production. Addition of CO donor mimicked the tanshinone IIA effect on suppressing inducible nitrite oxygen synthease (iNOS) and MMP-9 expression. Scavenge of CO by hemoglobin (Hb) reversed the inhibition due to tanshinone IIA. Inhibition of nitric oxide (NO) production by l-NAME inhibited MMP-9 expression due to tanshinone IIA. Taken together, these results suggest that tanshinone IIA exerts its inhibitory effect through induction of HO-1 expression. HO-1 catalyzes the formation of CO, which in turn inhibit iNOS induction. Inhibition of iNOS expression subsequently reduces the MMP-9 protein level and activity.